Enterocolitis, Pseudomembranous

An acute inflammation of the INTESTINAL MUCOSA that is characterized by the presence of pseudomembranes or plaques in the SMALL INTESTINE (pseudomembranous enteritis) and the LARGE INTESTINE (pseudomembranous colitis). It is commonly associated with antibiotic therapy and CLOSTRIDIUM DIFFICILE colonization.

Drugs by status

Approved for this indication (2)

clindamycin
lincomycin

Phase 4 trials (6)

bifidobacterium animalis
vancomycin
oligofructose
oxygen
bezlotoxumab
lactobacillus rhamnosus

Phase 3 trials (5)

metronidazole
sodium polystyrene sulfonate
tolevamer
rifampin
nitazoxanide

Phase 2 trials (1)

human fecal microbiota

Organizations

Organization Involved with Phase 4 Indications (4)

Baylor University
Harvard University
Icahn School of Medicine at Mount Sinai
Department of Veteran Affairs

Organization Involved with Phase 3 Indications (3)

Genzyme
McMaster University
The Physicians' Services Incorporated Foundation

Organization Involved with Phase 2 Indications (2)

Duke University
Catholic University of Sacred Heart, Rome

Organization Involved with Other Experimental Indications (2)

United States Army
Oakland University